RxElite, Inc.

RXEI · OTC
Analyze with AI
12/31/2007
9/30/2006
9/30/2005
9/30/2004
Assets
Cash & Equivalents$10,114$50$3
Short-Term Investments$0$0$0
Receivables$969$301$128
Inventory$7,353$10$5
Other Curr. Assets$94$1$0
Total Curr. Assets$18,530$362$137
Property Plant & Equip (Net)$1,833$29$37
Goodwill$0$0$0
Intangibles$67$0$0
Long-Term Investments$0$0$0
Tax Assets$0$0$0
Other NC Assets$836$0$0
Total NC Assets$2,736$29$37
Other Assets$0$0$0
Total Assets$21,266$391$174
Liabilities
Payables$5,721$57$47
Short-Term Debt$477$0$0
Tax Payable$0$0$0
Deferred Revenue$0$0$0
Other Curr. Liab.$947$96$33
Total Curr. Liab.$7,145$153$80
LT Debt$113$0$0
Deferred Rev, NC$0$0$0
Deferred Tax Liab, NC$0$0$0
Other NC Liab.$1,702$0$0
Total NC Liab.$1,814$0$0
Other Liabilities$0$0$0
Cap. Leases$57$0$0
Total Liabilities$8,960$153$80
Equity
Pref Stock$0$0$0
Common Stock$97$11$10
Retained Earnings-$28,636$227$84
AOCI$0$0$0
Other Equity$40,846$0$0
Total Equity$12,307$238$94
Supplemental Information
Minority Interest$0$0$0
Total Liab. & Tot. Equity$21,266$391$174
Net Debt-$9,523-$50-$3$0